Motohiro Okada

62PUBLICATIONS
12CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesSensory processes, perception and performanceGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (62)

|Aug 13, 2026
Development of glutamatergic antipsychotics requires efficient synaptic glutamatergic transmission while preventing NMDA receptor down-regulation and overactivation of extrasynaptic transmission.

|Jun 25, 2026
Risk of Long-Term Clozapine Medication over Decades for Cardiac Adverse Events Including Heart Failure and Its Pathophysiology: A Japan and China Retrospective Cohort Analysis.

|Apr 25, 2026
Combined Inhibition of TRPM4/NMDA Receptor Complex and Extrasynaptic NMDA Receptors Is Candidate Therapeutic Target for Suppression of Epileptic Seizures and Improvement of Cognitive Impairments.

|Feb 27, 2026
Temporal Dynamics of Auditory Evoked Neural Oscillations Under a Paired-Pulse Suppression Paradigm.

Tomosuke Nakano, Eishi Motomura, Kazuki Hisatomi

|Nov 28, 2025
Exploring effects of chronic d-cycloserine administration on expression of GluN2 subunits and tripartite synaptic transmission in thalamocortical pathway.

Motohiro Okada, Ruri Okubo, Nobutomo Yamamoto

|Oct 29, 2025
Paired Pulse Suppression and Prepulse Inhibition in Patients with Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder.

Dai Suzuki, Eishi Motomura, Kazuki Hisatomi

Pageof 11

Frequent Collaborators

10 joint publications

Eishi Motomura

6 joint publications

Kouji Fukuyama

5 joint publications

Ryusuke Matsumoto

4 joint publications

Ruri Okubo